Deciphering alzheimer disease

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 1, 2012, Pages

  Selkoe, Dennis ^a   Mandelkow, Eckhard ^b,c   Holtzman, David ^d  

^a Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

^b MAX PLANCK UNIT FOR STRUCTURAL MOLECULAR BIOLOGY   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; PRESENILIN; TAU PROTEIN; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; AWARENESS; CLINICAL TRIAL (TOPIC); COGNITION; COMPETITION; HUMAN; MEDICAL RESEARCH; MEMORY; MOLECULAR BIOLOGY; MOTIVATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PREVALENCE; SCIENTIST; STIMULATION; GENETICS; METABOLISM; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOMEDICAL RESEARCH; HUMANS;

EID: 84862221040     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a011460     Document Type: Article

References (39)

1. Aisen PS, Cummings JL, Schneider LS. 2011. Symptomatic and non-amyloid/tau-based pharmacologic treatment for Alzheimer disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006395.
2. Alzheimer A. 1907. Ueber eine eigenartige Erkrankung der Hirnrinde. Centralblatt fur Nervenheilkunde und Psychiatrie 30: 177-179.
3. Blennow K, Zetterberg H, Fagan AM. 2011. Fluid biomarkers in Alzheimer disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006221.
4. Blessed G, Tomlinson BE, Roth M. 1968. The association between quantitative measures of dementia and senile change in the cerebral grey matter of elderly subjects. Br J Psychiat 114: 797-811.
5. Brion J, Passareiro E, Nunez J, Flament-Durand J. 1985. Mise en evidence immunologique de la protein tau au niveau des lesions de degenerescence neurofibrillaire de la maladie D'Alzheimer. Arch Biol 95: 229-235.
6. De Strooper B, Iwatsubo T, Wolfe MS. 2011. Presenilisn and γ-secretase: Structure, function, and role in Alzheimer disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006304.
7. Glenner GG, Wong CW. 1984a. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122: 1131-1135.
8. Glenner GG, Wong CW. 1984b. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885-890.
9. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, GiuffraL, Haynes A, Irving N, James L, et al. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706.
10. Goedert M, Ghetti B, Spillantini MG. 2011. Frontotemporal dementia: Implications for understanding Alzheimer disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006254.
11. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung Y-C, Zaidi MS, Wisniewski HM. 1986. Microtubule-associated protein tau: A component of Alzheimer paired helical filaments. J Biol Chem 261: 6084-6089.
12. Haass C, Kaether C, Sisodia S, Thinakaran G. 2011. Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006270.
13. Holtzman DM, Herz J, Bu G. 2011a. Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006312.
14. Holtzman DM, Mandelkow E, Selkoe DJ. 2011b. Alzheimer disease in 2020. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a011585.
15. Ihara Y, Morishima-Kawashima M, Nixon R. 2011. The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006361.
16. Johnson KA, Fox NC, Sperling RA, Klunk WE. 2011. Brain imaging in Alzheimer diseae. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006213.
17. Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H, Multhaup G, Beyreuther K, Muller-Hill B. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736.
18. Katzman R. 1976. Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. Arch Neurol 33: 217-218.
19. Kidd M. 1964. Alzheimer's disease-An electron microscopical study. Brain 87: 307-320.
20. Kosik KS, Joachim CL, Selkoe DJ. 1986. Microtubule-associated protein, tau, is a major antigenic component of paired helical filaments in Alzheimer's disease. Proc Natl Acad Sci 83: 4044-4048.
21. LaFerla F, Green KN. 2011. Animal models of Alzheimer disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006320.
22. Lee V, Brunden KR, Hutton M, Trojanowski JQ. 2011. Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006437.
23. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van DuinenSG, Bots GTAM, Luyendijk W, Frangione B. 1990. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch-type. Science 248: 1124-1126.
24. Mandelkow EM, Mandelkow E. 2011. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006247.
25. Masters CL, Selkoe DJ. 2011. Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harb Pespect Med doi: 10. 1101/cshperspect. a006262.
26. Mayeux R, Stern Y. 2011. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006239.
27. Mucke L, Selkoe DJ. Neurotoxicity of amyloid β-protein: Synaptic networkdysfunction. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006338.
28. Müller UC, Zheng H. 2011. Physiological functions of APP family proteins. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006288.
29. Nukina N, Ihara Y. 1986. One of the antigenic determinants of paired helical filaments is related to tau protein. J Biochem 99: 1541-1544.
30. Sagare AP, Bell RD, Zlokovic BV. 2011. Neutovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a011452.
31. Saido T, Leissring MA. 2011. Proteolytic degradation of amyloid β-protein. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006379.
32. Schenk D, Basi GS, Pangalos MN. 2011. Treatment strategies targeting amyloid β-protein. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006387.
33. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. 2011. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006189.
34. Tanzi RE. 2011. The genetics of Alzheimer disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006296.
35. Tarawneh R, Holtzman DM. 2011. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006148.
36. Terry RD. 1963. The fine structure of neurofibrillary tangles in Alzheimer's disease. J Neuropathol Exp Neurol 22: 629-642.
37. Weintraub S, Wicklund AH, Salmon DP. 2011. The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006171.
38. Wood JG, Mirra SS, Pollock NL, Binder LI. 1986. Neurofibrillary tangles of Alzheimer's disease share antigenic determinants with the axonal microtubule-associated protein tau. Proc Natl Acad Sci 83: 4040-4043.
39. Wyss-Coray T, Rogers J. 2011. Inflammation in Alzheimer disease-A brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006346.